MarketCap
Facebook
X
TelegramAuris Medical Holding Ltd. EV/EBITDA | EARS
EV/EBITDA Jährlich Auris Medical Holding Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 0.463 | -0.387 | -0.267 | -0.488 | -0.62 | -3.06 | -2.47 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.463 | -3.06 | -0.976 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Sigilon Therapeutics
SGTX
|
-1.08 | - | - | $ 728 M |  USA |
 |
Rubius Therapeutics
RUBY
|
-0.028 | - | -33.55 % | $ 7.81 M | USA |
 |
Aptinyx
APTX
|
0.293 | - | -39.0 % | $ 4.57 M | USA |
 |
TRACON Pharmaceuticals
TCON
|
0.288 | - | -1.38 % | $ 46.8 M | USA |
 |
Mirati Therapeutics
MRTX
|
-3.35 | - | - | $ 3.3 B | USA |
 |
Revance Therapeutics
RVNC
|
-3.18 | - | - | $ 309 M | USA |
 |
Allogene Therapeutics
ALLO
|
-3.13 | $ 0.93 | -11.99 % | $ 205 M | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
0.956 | - | -37.48 % | $ 476 K | USA |
 |
Epizyme
EPZM
|
-0.12 | - | - | $ 249 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
0.361 | - | -9.72 % | $ 5.89 M | USA |
 |
ORIC Pharmaceuticals
ORIC
|
-7.05 | $ 8.9 | -3.63 % | $ 781 M | USA |
 |
Forward Pharma A/S
FWP
|
-132 | - | -0.75 % | $ 18.7 M |  Danmark |
 |
Orchard Therapeutics plc
ORTX
|
-5.82 | - | 1.02 % | $ 90.8 M |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
11.3 | - | - | $ 154 M | USA |
 |
Oyster Point Pharma
OYST
|
-2.51 | - | - | $ 300 M | USA |
 |
Nabriva Therapeutics plc
NBRV
|
-0.365 | - | - | $ 4.55 M |  Irlanda |
 |
Intercept Pharmaceuticals
ICPT
|
-60.9 | - | - | $ 643 M | USA |
 |
NGM Biopharmaceuticals
NGM
|
-0.613 | - | - | $ 127 M | USA |
 |
Regulus Therapeutics
RGLS
|
0.619 | - | - | $ 155 M | USA |
 |
9 Meters Biopharma
NMTR
|
-0.847 | - | -42.97 % | $ 1.05 M | USA |
 |
Chinook Therapeutics
KDNY
|
-7.76 | - | - | $ 2.6 B | USA |
 |
Lumos Pharma
LUMO
|
-0.078 | - | - | $ 35.3 M | USA |
 |
Syros Pharmaceuticals
SYRS
|
-0.204 | - | -8.44 % | $ 3.4 M | USA |
 |
NanoViricides
NNVC
|
-3.68 | $ 1.44 | 8.27 % | $ 29.1 M | USA |
 |
Gamida Cell Ltd.
GMDA
|
-3.61 | - | -18.25 % | $ 5.04 M |  Israel |
 |
GT Biopharma
GTBP
|
0.233 | $ 3.99 | -7.64 % | $ 22 M | USA |
 |
Aravive
ARAV
|
-0.832 | - | -13.39 % | $ 1.45 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-3.44 | - | -74.18 % | $ 955 K | USA |
 |
BioLineRx Ltd.
BLRX
|
-550 | $ 1.52 | -3.8 % | $ 3.75 B | Israel |
 |
VistaGen Therapeutics
VTGN
|
-0.055 | $ 0.18 | -0.46 % | $ 6.85 M | USA |
 |
C4 Therapeutics
CCCC
|
-2.31 | $ 3.0 | -4.76 % | $ 249 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
0.0726 | $ 1.67 | -0.6 % | $ 2.75 M | Israel |
 |
Cytokinetics, Incorporated
CYTK
|
-3.27 | $ 56.2 | 1.92 % | $ 6.75 M | USA |
 |
Curis
CRIS
|
-3.41 | $ 0.66 | -5.68 % | $ 8.69 M | USA |
 |
Exelixis
EXEL
|
13.2 | $ 71.0 | -1.04 % | $ 19.3 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Amgen
AMGN
|
13.3 | $ 465.26 | 0.01 % | $ 250 B | USA |
 |
Biogen
BIIB
|
48.2 | $ 253.37 | -0.59 % | $ 37.1 B | USA |
 |
Edesa Biotech
EDSA
|
-0.0637 | $ 2.01 | -19.28 % | $ 11.4 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-15 | $ 15.12 | -0.72 % | $ 978 M | USA |
 |
Achieve Life Sciences
ACHV
|
552 | $ 6.78 | 0.89 % | $ 296 M | USA |
 |
Fulcrum Therapeutics
FULC
|
-4.3 | $ 3.72 | -0.13 % | $ 236 M | USA |
 |
Immutep Limited
IMMP
|
-2.76 | $ 3.53 | -7.11 % | $ 5.14 B |  Australia |
 |
Iovance Biotherapeutics
IOVA
|
-0.135 | $ 8.09 | -1.04 % | $ 2.89 M | USA |
 |
Evogene Ltd.
EVGN
|
-0.106 | $ 0.37 | 28.7 % | $ 2.91 M | Israel |
 |
Armata Pharmaceuticals
ARMP
|
-17.1 | $ 3.71 | -2.5 % | $ 134 M | USA |
 |
Axsome Therapeutics
AXSM
|
-53.8 | $ 141.12 | 5.34 % | $ 7.02 B | USA |
 |
Keros Therapeutics
KROS
|
3.77 | $ 9.32 | 1.64 % | $ 347 M | USA |
|
Champions Oncology
CSBR
|
392 | $ 4.85 | 0.21 % | $ 67.1 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
-26.6 | $ 10.6 | -2.12 % | $ 303 M | USA |